chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On day 19 after the vaccine was given I tested them for antibodies to the virus, they both were negative for IgM and IgG.; This is a spontaneous report from a contactable physician. This physician reported similar events for 2 patients. This is 2nd of 2 reports. A 78-year-old patient of an unspecified gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date unspecified), via an unspecified route of administration on 29Dec2020 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The physician reported that the couple was vaccinated on the same day in the same vehicle at a drive-through vaccination site. Both patients had no symptoms after the vaccination. On 17Jan2021, on day 19 after the vaccine was given, the patient was tested for antibodies to the virus, and both were negative for IgM and IgG; the control was positive. The test was negative for both IgM and IgG for both patients. The physician was asking if the first shot was not given properly and if they need a third vaccination. The physician was concerned that there may be an issue with the sensitivity of the office test. All of their friends have had at least some arm discomfort after the vaccine, they were nervous about the vaccine not working. Outcome of event was unknown.  Information on lot/Batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021063846 same reporter/drug/event, different patient
I had really strong aches that woke me up in the middle of the night. I took pain meds in the morning and have a 100.5/100.6 fever all long. I took meds twice but fever would not break. It eventually decreased around 7pm that evening and was back to normal around 9pm.  I also had nausea and dizziness.  Experienced palpitations during following days.
Site: Itching at Injection Site-Mild, Site: Pain at Injection Site-Mild, Additional Details: Patient expressed tingling in arm and throat, administered benadryl; we observed her for 30 min and left with no issue. we called her 4 hours later and spoke with her by phone , all is good. no lingering effect
Information has been received regarding a case in litigation concerning a 5 year old female who prior to vaccination was described as being "a well and healthy, normally developing, happy young girl" who on 8/10/00 was vaccinated with MMRII. It was reported that the pt subsequently developed a high fever, severe salmon colored rash and extreme pain in her lower extremity joints. She was admitted to the hospital on 9/29/00 and discharged from the hospital on 10/6/00. She was dx'd with systemic juvenile rheumatoid arthritis or "Still's disease". The pt had "profound" pain in her lower extremities and joints, difficulty walking, poor appetite, nausea, weight loss, arthritis, fever, hair loss and severe rashes over her entire body, rendering her permanently and totally disabled. It was expected that she would continue to suffer mental and physical impairments and pain in the future. Systemic juvenile rheumatoid arthritis was reported to be disabling. No further information is available.
I developed swelling and pain in my left calf. I went to my doctor and I was prescribed a three month duration of ELIQUIS.
Redness in left eye, pain in left eye socket, blistering on left side of nose,  left side of scalp sensitive to touch, left ear odd sensation, left jaw joint odd sensation, left side of throat sore ( missing tonsil location) . NP diagnosed allergy reaction, prescribed methylprednisolone - 6 day course.  Symptoms seemed to abate and then returned after completion of Mpred.  Pain in left eye at times severe.  Using cold compress.  Taking 2 - 500mg acetaminophen every 6 hours for pain.  It helps!
Patient is a 52 year old female who presents with concerns of headaches, nausea, fatigue, hives/itching, and SOB since receiving her Covid-19 vaccine 3 weeks ago. Got the Pfizer vaccine at the Center on 1/17/21 around 12:30PM. She had no side effects during the 15 minutes she was kept for observation after receiving the vaccine. She did develop a headache and fatigue approximately 1.5 hours after she got the vaccine and then later that day developed nausea. SOB developed the following day. She developed hives on her chest approximately 2-3 days after the vaccine. States she cannot recall the exact date that the hives started. Hives have appeared like pink raised plaques. Largest plaque was 1 inch in diameter she estimates. The hives have continued to come and go from different areas of her body including her shoulders, buttock, upper legs. SOB is present at rest and with exertion. She has had no chest pain/pressure/tightness/wheezing , palpitations, or feeling of her throat closing. States her exertion capacity is reduced.
Patient presented with dime sized nodules on her upper arms and collarbone area. Appeared pink and patient stated they were firm. Patient stated they appeared a "few days" after her immunization. She could think of no other changes to food, medication, hygiene, or habits that may have caused this reaction. Patient mentioned that her doctor mentioned something about lymph nodes but these nodules were not located in typical lymph node locations.
17year old received the Moderna Covid-19 vaccine; Pregnant patient receive the Moderna Covid-19 vaccine; This spontaneous prospective pregnancy case was reported by a health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17year old received the Moderna Covid-19 vaccine) and MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient receive the Moderna Covid-19 vaccine) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17year old received the Moderna Covid-19 vaccine) and MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient receive the Moderna Covid-19 vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17year old received the Moderna Covid-19 vaccine) outcome was unknown and MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient receive the Moderna Covid-19 vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications was provided by the reporter. No Treatment medications was provided by the reporter.
Extreme pain in Right Knee; Severe body aches; chills; This is a spontaneous report from a contactable consumer (patient). A 70-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6207) via an unspecified route of administration in the right arm on 11Mar2021 14:45 (at the age of 70-years-old) as DOSE 1, SINGLE for COVID-19 immunization. The patient's medical history included fibromyalgia and urinary tract infection (UTI) from an unknown date and unknown if ongoing. Concomitant medications included mirabegron (MYRBETRIQ) for UTI from 02Mar2021 to 15Mar2021 and nitrofurantoin (MACROBID) for UTI from 06Mar2021 to 12Mar2021. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 12Mar2021 20:00, the patient experienced severe body aches and chills which were lasted approximately 24 hours and stopped. On 13Mar2021 at 17:00, she had extreme pain in right knee, she could not put any weight on it and had severe pain for 10 days. Her pain slowly went away after 2 weeks. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events included chiropractic muscle massage and steam. The clinical outcome of the events chills and severe body aches was recovered on an unspecified date in Mar2021, while the outcome of the event extreme pain in right knee was recovered on an unspecified date in 2021.   No follow-up attempts are needed. No further information is expected.
Tingling; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Durolane Hyaluronic Acid injection (Dermal filler-Durolane injection in her knee) in 2019 and Flu shot (Flu shot 3 weeks ago) in 2021. Past adverse reactions to the above products included No adverse event with Durolane Hyaluronic Acid injection and Flu shot.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (Tingling). At the time of the report, PARAESTHESIA (Tingling) outcome was unknown.            No concomitant medication was provided. No treatment medication was provided. Patient had been experiencing tingling on and off for more than a month
Had chills for 3 or 4 hours after receiving the vaccine; This spontaneous case was reported by a non-health professional and describes the occurrence of CHILLS (Had chills for 3 or 4 hours after receiving the vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (Had chills for 3 or 4 hours after receiving the vaccine). At the time of the report, CHILLS (Had chills for 3 or 4 hours after receiving the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.
Within one hour of injection - numb lips, tongue; swollen throat; labored breathing; heavy arm; headache, nausea, dizzyness
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Nurse) from product quality group. The reporter is the patient.  A 58-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 18Feb2021 as dose 1, single (Lot number: EN6201), in right arm, on 11Mar2021 as dose 2, single (Lot number: EN6206), in left arm, on 05Oct2021 as dose 3 (booster), single (Lot number: EV0191), in left arm and on 15Apr2022 as dose 4 (booster), single (Lot number: FK9729) at the age of 58 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "S/P Breast CA with rads tx and Tamoxifen" (unspecified if ongoing), notes: S/P Breast CA with rads tx and Tamoxifen; "IBM" (unspecified if ongoing); "Hashimoto's Thyroiditis" (unspecified if ongoing); "S/P Breast CA with rads tx and Tamoxifen" (unspecified if ongoing), notes: S/P Breast CA with rads tx and Tamoxifen. Concomitant medication(s) included: TAMOXIFEN taken for breast cancer female; LEVOTHYROXINE; MOXIFLOXACIN. Past drug history included: Reflex, reaction(s): "known allergies: reflex", notes: known allergies: reflex. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset May2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of vaccination failure, covid-19.  No follow up attempts are needed. No Further information is expected.
flu; Initial information received on 18-Oct-2020 regarding an unsolicited valid non-serious social media case from consumer (patient).  This case is linked to case 2020SA296404.  This case involves a patient of an unknown demographic who got the flu (influenza), when received vaccine INFLUENZA VACCINE.  The patient's medical history, medical treatments, vaccinations,concomitant medications and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiry date not reported) via an unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient got the flu (influenza) within 24 hours following the administration of INFLUENZA VACCINE.  No laboratories details reported.  It was not reported if the patient received a corrective treatment.  The outcome of event was unknown, at the time of reporting.  There will be no information available on the batch number for this case.
Dizziness, Fever, NauseaVomiting, chest pain, temp 102.0 Narrative:
approx 2 minutes p/receiving MMR vax pt walked to waiting area & pt fell to the floor; w/in seconds pt clenched teeth, flexed both upper arms this episode lasted approx 20 seconds; pt woke up alert & oriented;
Fevers, seizures within 2 days of immunization, lasted 1 week.
On 2/25/2004 mother brought her child in for immunizations. On 2/26/2004 mother brought the child back to the office stating that his arm was swollen. She stated that she notice it last night; she was not sure of the time. Upon examination the left deltoid was noticeably red, sollen, and feverish. Mother stated that the child had not other complaints other than his left arm. She was encouraged to give the child an inti-inflammatory (Motrin)to help with the swelling. Mother was also told that if the pain or swelling became worse that she should she should contact her family physician or if after hours go to the ER. Provider will contact patient in AM to see if there has been any improvement.
Urticaria, hives, and itching that developed 72 hours after receiving immunizations. Symptoms have resolved with the use of Benadryl, but returned x 3-4 days.
Fever of 99.7; This is a spontaneous report from a contactable consumer (patient himself). A 65-year-old male patient received the second dose of bnt162b2 (formulation: solution for injection, lot number: EL9262), via intramuscularly in left arm on 24Feb2021 at 16:30 as single dose for COVID-19 immunisation. The patient's medical history included prosthetic mitral valve and previously took the first dose of bnt162b2 (Lot Number: EJ1686), via in left arm on 02Feb2021 at 11:30 as single dose for COVID-19 immunisation. The patient did not had allergy to medications, food or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 25Feb2021 at 10:00, the patient experienced fever. At 14:00, the patient's body temperature was 99.7. Therapeutic measures were not received in response to the event. The outcome of the event was recovering.
It started with significant neck pain. I went to the back doctor and he did an x-ray, and the radiologist upgraded my degenerative disk disease to a severe level. I had a fibromyalgia flare up. I had increase in pain and fatigue. My fatigue is at a severe level since October. In January I had cervical injection. It helped my neck pain. I had to increase my pain medicines. I am back to my normal pain medicine. My fatigue continues to be at a severe level. My doctor diagnosed with chronic fatigue syndrome. They were sending me to the (Privacy) for the chronic fatigue condition. But they said they do not treat that condition, so they rejected me. My 2 rheumatologists recommended me to exercise, but I have exercise intolerance fatigue so that did not help. One of my doctors did a bunch of blood work and my iron binding capacity is low, ANA is slightly high, white blood count is slightly high. My D-dimer was abnormally high. I went to the ER on 02/02/2022 for stomach pain and like 2 or 3 days they did an endoscopy. I also developed Barrett's esophagus and chemical gastropathy. I lost weight and I have decrease appetite. I get full very fast and I can't eat normally. The stomach issues started also in October. We also did genetic tests and I carry a gene for hemochromatosis but I do not have the disease. I also had a benign breast lump in 09/2021.
10 days after the first vaccine I experienced chest pain, difficulty breathing and a rapid heart beat. 9 weeks after the second dose I had to go to the hospitial with a rapid heartbeat of 229 BPM. Since then I have experienced multiple heart events with rapid heartbeats exceeding 150 BPM and as high as 229 BPM. The cardiologist has diagnosed me with atrial fibrilation, atrial tachycardia and heart flutter. He is recommending numerous surgeries.
My left arm - around the injection site - suddenly became warm, itchy, red, and swollen on the evening of 1/23. I took some ibuprofen but was still unable to sleep that night due to the discomfort. The next morning the swelling and pain was worse - I called and spoke to a nurse. Gave her my symptoms and medical history. She shared my concern about a possible DVT (I previously had a DVT in my right arm in 2008). I then went to the ER to have an ultrasound - Dr did rule out a DVT and stated that it was likely just an adverse reaction to the vaccine. Over the next several days the swelling went down, but a red itchy rash continued for the next 7 days.
Red itchy bumps / blisters form on hands, feet, thighs, and arms.  The bumps / blisters mirror both sides of body. The rash lasts for a week, and heals in about 2 weeks after initial rash begins.
pt recv vax; approx 1 hr later, devel localized rash at inject site on inner aspect of arm & mild HA;f/u RN reported pt moved away;
Received PCV-13 vaccine as part of routine vaccination. On 3/25/18 patient began with pain at the site of the injection and redness. By 3/27/18 patient came into PCP office for assessment of arm with increased redness, swelling, induration, streaking of redness several inches down arm from where injection site was. She was treated with KEFLEX for suspected cellulitis secondary to injection. On 3/31/18 patient presented to emergency department with worsening cellulitis extending from site that was assessed at visit in PCP office. Admission was warranted, patient was treated with ANCEF and Vancomycin intravenously for 2 days with resolution of cellulitis. Discharged home with oral antibiotics. Check in with patient on 4/6/18 and verbalization of complete resolvement of infection.
Night following vaccine (1/25): Arm soreness Morning following (1/26; 7:00am): Fever 101.1, chills, sweats, arm soreness Throughout day (1/26): Fever up to 102, chills, sweats, fatigue, no appetite, arm soreness and extreme headache. Could not complete anything that required any type of focus such as watch TV/go on phone, the light increased headache. Slept on and off all day. Evening (1/26; 4:30pm): Took Excedrin for headache, was told by other coworkers not to medicate until 24 hours after at least, so did not take anything up to this point just in case. Slept another 2 hours, woke up extremely sweaty, fever had broken to 99.1, and headache was gone.
dizziness on and off for 2 months; vertigo; Injection site started to hurt really bad; Body aches; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness on and off for 2 months), VERTIGO (vertigo), VACCINATION SITE PAIN (Injection site started to hurt really bad), MYALGIA (Body aches) and HEADACHE (Headaches) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     Concurrent medical conditions included Prostate cancer.   On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced VACCINATION SITE PAIN (Injection site started to hurt really bad), MYALGIA (Body aches) and HEADACHE (Headaches). On an unknown date, the patient experienced DIZZINESS (dizziness on and off for 2 months) and VERTIGO (vertigo). At the time of the report, DIZZINESS (dizziness on and off for 2 months) and VERTIGO (vertigo) outcome was unknown and VACCINATION SITE PAIN (Injection site started to hurt really bad), MYALGIA (Body aches) and HEADACHE (Headaches) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.2 (High) temperature of 100.2 F.         No relevant concomitant medications reported. No treatment information was provided.    Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Additional information include patient demographic details and events updated.
fever; nausea; headache; fatigue; couldn't sleep; This case was reported by a other health professional via call center representative and described the occurrence of fever in a 56-year-old female patient who received Herpes zoster (Shingrix) (batch number 494PR, expiry date 13th September 2021) for prophylaxis.   On 24th June 2019, the patient received the 2nd dose of Shingrix (intramuscular). On 24th June 2019, less than a day after receiving Shingrix, the patient experienced fever, nausea, headache, fatigue and sleeplessness. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the fever was recovering/resolving and the outcome of the nausea, headache, fatigue and sleeplessness were unknown.   It was unknown if the reporter considered the fever, nausea, headache, fatigue and sleeplessness to be related to Shingrix.  Additional information received were as follows: The patient received Shingrix on the right arm. The healthcare professional reported that the patient's body temperature was recorded as 100.1 degree F. The patient could not sleep the night she received her second dose of Shingrix. The office instructed patient on 25th June 2019 to call back if symptoms did not resolve in 24 hours and the patient had not called back. The reporter consented to follow up.
Had redness and swelling about silver dollar size over right shoulder at site of DTaP/IPV injections. No systemic symptoms. Resolved in 48 hours.
Patient was mistakenly given high dose influenza vaccine, but patient is only 63 years old. No reported Adverse events from the vaccine itself.
got sick; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced sickness (Verbatim: got sick). The outcome of the sickness was unknown.   It was unknown if the reporter considered the sickness to be related to Shingles vaccine.     It was unknown if the company considered the sickness to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 23-APR-2023. Case was reported by a consumer via interactive digital media. The reporter stated that If have diabetes, the vaccine was not highly recommended, and when defenses were low, remember that it was the virus that you were injected with,  The reporter stated he/she worked with people who got sick immediately after they got the vaccine.